Background and aims: Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can improve the cardiovascular prognosis. We evaluated the long-term cardiovascular risk of HeFH using the French REgistry of Familial hypERCHOLesterolemia (REFERCHOL).Methods: We studied HeFH patients diagnosed genetically and...
-
2022 (v1)Journal articleUploaded on: July 4, 2024
-
2022 (v1)Journal article
Background and aims: Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can improve the cardiovascular prognosis. We evaluated the long-term cardiovascular risk of HeFH using the French REgistry of Familial hypERCHOLesterolemia (REFERCHOL).Methods: We studied HeFH patients diagnosed genetically and...
Uploaded on: July 4, 2024